Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Melarsoprol Resistance in African Trypanosomiasis
Alan H. Fairlamb, David Horn
Trends in Parasitology (2018) Vol. 34, Iss. 6, pp. 481-492
Open Access | Times Cited: 109

Showing 1-25 of 109 citing articles:

An Overview of Drug Resistance in Protozoal Diseases
Rita Capela, Rui Moreira, Francisca Lopes
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 22, pp. 5748-5748
Open Access | Times Cited: 158
Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials
Xin Xie, Tingting Yu, Xiang Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 154
Anti-trypanosomatid drug discovery: progress and challenges
Manu De Rycker, Susan Wyllie, David Horn, et al.
Nature Reviews Microbiology (2022) Vol. 21, Iss. 1, pp. 35-50
Open Access | Times Cited: 126
Arsenic in medicine: past, present and future
Ngozi P. Paul, Adriana E. Galván, Kunie Yoshinaga-Sakurai, et al.
BioMetals (2022) Vol. 36, Iss. 2, pp. 283-301
Open Access | Times Cited: 72
New Drugs for Human African Trypanosomiasis: A Twenty First Century Success Story
Emily A. Dickie, Federica Giordani, Matthew K. Gould, et al.
Tropical Medicine and Infectious Disease (2020) Vol. 5, Iss. 1, pp. 29-29
Open Access | Times Cited: 117
Clinical and veterinary trypanocidal benzoxaboroles target CPSF3
Richard J. Wall, Eva Rico, Iva Lukač, et al.
Proceedings of the National Academy of Sciences (2018) Vol. 115, Iss. 38, pp. 9616-9621
Open Access | Times Cited: 108
Human African Trypanosomiasis (sleeping sickness): Current knowledge and future challenges
Roberta Papagni, Roberta Novara, Maria Letizia Minardi, et al.
Frontiers in Tropical Diseases (2023) Vol. 4
Open Access | Times Cited: 30
Drug resistance in animal trypanosomiases: Epidemiology, mechanisms and control strategies
Marzuq A. Ungogo, Harry P. de Koning
International Journal for Parasitology Drugs and Drug Resistance (2024) Vol. 25, pp. 100533-100533
Open Access | Times Cited: 13
Antimicrobials and resistance part II: Antifungals, antivirals, and antiparasitics
Fiorinda F. Muhaj, Saira George, Celine Nguyen, et al.
Journal of the American Academy of Dermatology (2022) Vol. 86, Iss. 6, pp. 1207-1226
Closed Access | Times Cited: 33
Discovery, Development, Inventions and Patent Review of Fexinidazole: The First All-Oral Therapy for Human African Trypanosomiasis
Mohd Imran, Shah Alam Khan, Mohammed Kanan Alshammari, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 2, pp. 128-128
Open Access | Times Cited: 29
Motility-based label-free detection of parasites in bodily fluids using holographic speckle analysis and deep learning
Yibo Zhang, Hatice Ceylan Koydemir, Michelle M. Shimogawa, et al.
Light Science & Applications (2018) Vol. 7, Iss. 1
Open Access | Times Cited: 56
Insights into antitrypanosomal drug mode-of-action from cytology-based profiling
J. Alero Thomas, Nicola Baker, Sebastian Hutchinson, et al.
PLoS neglected tropical diseases (2018) Vol. 12, Iss. 11, pp. e0006980-e0006980
Open Access | Times Cited: 53
Screening Marine Natural Products for New Drug Leads against Trypanosomatids and Malaria
María Álvarez Bardón, Yolanda Pérez‐Pertejo, C. Ordóñez, et al.
Marine Drugs (2020) Vol. 18, Iss. 4, pp. 187-187
Open Access | Times Cited: 47
Drug Resistance in Protozoan Parasites: An Incessant Wrestle for Survival
Pijush Kanti Pramanik, Md Nur Alam, Dibyapriya Roy Chowdhury, et al.
Journal of Global Antimicrobial Resistance (2019) Vol. 18, pp. 1-11
Closed Access | Times Cited: 44
Anti-inflammatory and immunomodulatory effects of mesenchymal stem cell therapy on parasitic drug resistance
Soheil Sadr, Pouria Ahmadi Simab, Mahta Niazi, et al.
Expert Review of Anti-infective Therapy (2024) Vol. 22, Iss. 6, pp. 435-451
Closed Access | Times Cited: 5
Suramin exposure alters cellular metabolism and mitochondrial energy production in African trypanosomes
Martin Zoltner, Gustavo D. Campagnaro, Gergana Taleva, et al.
Journal of Biological Chemistry (2020) Vol. 295, Iss. 24, pp. 8331-8347
Open Access | Times Cited: 38
Structure-Based Optimization of Quinazolines as Cruzain and TbrCATL Inhibitors
Elany Barbosa da Silva, Débora Assumpção Rocha, Isadora Serraglio Fortes, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 17, pp. 13054-13071
Closed Access | Times Cited: 28
Structure-activity relationship of dibenzylideneacetone analogs against the neglected disease pathogen, Trypanosoma brucei
Karol R. Francisco, Ludovica Monti, Wenqian Yang, et al.
Bioorganic & Medicinal Chemistry Letters (2023) Vol. 81, pp. 129123-129123
Open Access | Times Cited: 11
Antimicrobial Peptides (AMPs): Potential Therapeutic Strategy against Trypanosomiases?
Maura Rojas-Pirela, Ulrike Kemmerling, Wilfredo Quiñones, et al.
Biomolecules (2023) Vol. 13, Iss. 4, pp. 599-599
Open Access | Times Cited: 11
Further Investigations of Nitroheterocyclic Compounds as Potential Antikinetoplastid Drug Candidates
Carlos García‐Estrada, Yolanda Pérez‐Pertejo, Bárbara Domínguez-Asenjo, et al.
Biomolecules (2023) Vol. 13, Iss. 4, pp. 637-637
Open Access | Times Cited: 11
Mechanisms of genotoxicity and proteotoxicity induced by the metalloids arsenic and antimony
Robert Wysocki, Joana Isabel Rodrigues, Ireneusz Litwin, et al.
Cellular and Molecular Life Sciences (2023) Vol. 80, Iss. 11
Open Access | Times Cited: 11
Identification of Substituted 4-Aminocinnolines as Broad-Spectrum Antiparasitic Agents
Andrew Spaulding, Amrita Sharma, Miriam A. Giardini, et al.
ACS Infectious Diseases (2025)
Open Access
Genetic Diversity in the Diminazene Resistance-Associated P2 Adenosine Transporter-1 (AT-1) Gene of Trypanosoma evansi
Shoaib Ashraf, Ghulam Yasein, Qasim Ali, et al.
Animals (2025) Vol. 15, Iss. 5, pp. 756-756
Open Access
Exploring bioactive molecules released during inter- and intraspecific competition: A paradigm for novel antiparasitic drug discovery and design for human use
Pichet Ruenchit
Current Research in Parasitology and Vector-Borne Diseases (2025), pp. 100256-100256
Open Access
Delivery of melarsoprol using folate-targeted PEGylated cyclodextrin-based nanoparticles for hepatocellular carcinoma
Yanan Li, Xiaoju Shi, Dandan Sun, et al.
International Journal of Pharmaceutics (2023) Vol. 636, pp. 122791-122791
Closed Access | Times Cited: 10
Page 1 - Next Page

Scroll to top